Syntec Optics (Nasdaq: OPTX) Secures $4.8M Order for Medical Diagnostics Optics
ROCHESTER, NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) — Syntec Optics (Nasdaq:OPTX), a leading innovator in optics and photonics technology, today announced a $4.8 million order from a major blue-chip customer for the supply of diagnostic electro-optics for various biomarker measurements at the point of care. This signifies a pivotal step in Syntec Optics’ ongoing commitment to developing cutting-edge solutions that improve patient outcomes and enhance healthcare delivery.
Related news for (OPTX)
- Breaking News: MoBot’s Latest Update as of 09/05/25 04:00 PM
- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Third Quarter 2024 Financial Results
- Syntec Optics (Nasdaq: OPTX) Delivers 50,000th Precision MicroLens Array for New End-Market
- Syntec Optics (Nasdaq: OPTX) to Display Innovations at Photonics West 2024